| Tenofovir Impurity H | 1280130-08-6 | C19H30N5O10P |
| Tenofovir Impurity J | 1246812-16-7 | C15H24N5O7P |
| Tenofovir Impurity K | 1246812-40-7 | C17H28N5O7P |
| Tenofovir Impurity M | 1422284-16-9 | C18H28N5O10P |
| Tenofovir Impurity O | 1244022-54-5 | C23H36N5O12P |
| Tenofovir Impurity P | 1255525-18-8 | C11H18N5O4P |
| Tenofovir Impurity R | 1643116-23-7 | C13H22N5O4P |
| Tenofovir Impurity S | 1246812-43-0 | C17H26N5O10P |
| Tenofovir Impurity T | 1244022-52-3 | C8H11N5O |
| Tenofovir Impurity U | 4121-39-5 | C8H9N5 |
| Tenofovir Impurity V | 180587-75-1 | C13H22N5O4P |
| Tenofovir Impurity W | 1244022-55-6 | C15H24N5O8P |
| Tenofovir Impurity X | 1878175-82-6 | C11H17N5O2 |
| Tenofovir Impurity Z | 161760-03-8 | C10H15O6PS |
| Tenofovir Isopropyl Ethyl Diester | 1422284-16-9 | C18H28N5O10P |
| Tenoxicam degradation impurity standard | 59804-37-4 | C13H11N3O4S2 |
| Tenoxicam Imp. A (EP): Pyridin-2-amine | 504-29-0 | C5H6N2 |
| Tenoxicam Imp. B (EP): Methyl 4-Hydroxy-2-methyl-2H- thieno[2,3-e]1,2-thiazine-3-carboxylate 1,1- Dioxide | 59804-25-0 | C9H9NO5S2 |
| Tenoxicam Imp. C (EP): N-Methylthiophene-2-carboxamide | 39880-77-8 | C6H7NOS |
| Tenoxicam Imp. E (EP): 2-Methylthieno[2,3-d]isothiazol- 3(2H)-one 1,1-Dioxide | 94040-09-2 | C6H5NO3S2 |
| Tenoxicam Imp. G (EP): 4-Hydroxy-2-methyl-2H-thieno-[2,3-e]1,2-thiazine- 3-carboxamide 1,1-Dioxide | 105410-48-8 | C8H8N2O4S2 |
| Tenoxicam Imp. H (EP): 3-[(Methylamino)sulphonyl]thiophene-2-carboxylic Acid | 64527-92-0 | C6H7NO4S2 |
| Tenoxicam Impurity 1 | 16817-89-3 | C7H8N2O3 |
| Teprenone | 6809-52-5 | C23H38O |
| Teprenone impurity 3 | 3796-69-8 | C18H30O |
| Teprenone impurity 4 | 3953-35-3 | C18H30O |
| Teprenone impurity 14 | 3879-23-0 | C23H38O |
| Teprenone impurity 16 (Farnesylaceton) | 1117-52-8 | C18H30O |
| Teprenone Impurity 19 (Trans-Nerolidol) | 40716-66-3 | C15H26O |
| Teprenone impurity 20 | 1117-51-7 | C18H30O |
| Teprenone Impurity 21 (Cis-Nerolidol) | 3790-78-1 | C15H26O |
| Teprenone impurity 22 | 109826-68-8 | C23H40O |
| Teprenone impurity 24 | 70901-63-2 | C20H32 |
| Teprenone Impurity 26 (Geranylgeraniol) | 24034-73-9 | C20H34O |
| Teprenone Impurity 27 (Geranylnerol) | 57784-25-5 | C20H34O |
| Teprenone impurity 30 | 3796-64-3 | C23H38O |
| Teprenone impurity 31 | 3879-24-1 | C23H38O |
| Teprenone impurity 32 | 3796-67-6 | C23H38O |
| Teprenone impurity 39 | 3796-63-2 | C23H38O |
| Teprenone impurity 41 | 3796-66-5 | C23H38O |
| Teprenone impurity 42 | 3879-25-2 | C23H38O |
| Terazosin EP impurity B | 1177261-73-2 | C19H24N4O5 |
| Terazosin EP impurity D | 102714-74-9 | C15H19N5O3 |
| Terazosin EP impurity F | 109678-71-9 | C19H27N5O4 |
| Terazosin EP impurity G | 105356-89-6 | C18H23N5O4 |
| Terazosin EP impurity H | 105356-90-9 | C18H23N5O4 |
| Terazosin EP impurity I | 1177261-85-6 | C20H27N5O4 |
| Terazosin EP impurity J | 152551-75-2 | C19H27N5O4 |
| Terazosin EP impurity K | 19216-56-9 | C19H21N5O4 |
| Terazosin EP impurity L | 40172-95-0 | C9H12N2O2 |
| Terazosin EP impurity M | 31350-27-3 | C14H14N2O4 |
| Terazosin EP impurity N | 63074-07-7 | C9H16N2O2 |
| Terazosin EP impurity O | 547730-06-3 | C14H22N2O4 |
| Terazosin for system suitability | 70024-40-7 | C19H30ClN5O6 |
| Terazosin for system suitability A | 70024-40-7 | C19H30ClN5O6 |
| Terazosin Hydrochloride Dihydrate Imp. A (EP): 2-Chloro-6,7-dimethoxy- quinazolin-4-amine | 23680-84-4 | C10H10ClN3O2 |
| Terazosin Hydrochloride Dihydrate Imp. C (EP): 6,7-Dimethoxy-2-(piperazin- 1-yl)quinazolin-4-amine | 60547-97-9 | C14H19N5O2 |
| Terazosin Hydrochloride Dihydrate Imp. D (EP) as Hydrochloride: 1-(4-Amino-6,7- dimethoxyquinazolin-2-yl)-4-formylpiperazine Hydrochloride | 84050-21-5 | C15H20ClN5O3 |
| Terazosin Hydrochloride Dihydrate Imp. E (EP): 2,2'-(Piperazine-1,4-diyl)bis(6,7- dimethoxyquinazolin-4-amine) | 102839-00-9 | C24H28N8O4 |
| Terazosin Hydrochloride Dihydrate Imp. K (EP) as Hydrochloride: Prazosin Hydrochloride | 19237-84-4 | C19H22ClN5O4 |
| Terazosin Hydrochloride Dihydrate Imp. L (EP): 1-(Furan-2-ylcarbonyl)piperazine | 40172-95-0 | C9H12N2O2 |
| Terazosin Hydrochloride Dihydrate Imp. M (EP): 1,4-Bis(furan-2-ylcarbonyl)- piperazine | 31350-27-3 | C14H14N2O4 |
| Terazosin Hydrochloride Dihydrate Imp. N (EP): 1-[[(2RS)-Tetrahydrofuran-2- yl]carbonyl]piperazine | 63074-07-7 | C9H16N2O2 |
| Terazosin Hydrochloride Dihydrate Imp. O (EP): 1,4-Bis[(tetrahydrofuran-2- yl)carbonyl]piperazine | 547730-06-3 | C14H22N2O4 |
| Terazosin impurity 1 | 1486464-41-8 | C24H30Cl2N8O4 |
| Terazosin impurity A | 23680-84-4 | C10H10ClN3O2 |
| Terazosin impurity E | 102839-00-9 | C24H28N8O4 |
| Terazosin impurity E | 102839-00-9 | C24H28N8O4 |
| Terazosin impurity L | 40172-95-0 | C9H12N2O2 |
| Terazosin impurity N | 63074-07-7 | C9H16N2O2 |
| Terazosin Related Compound A | Not available | C14H25Cl2N5O4 |
| Terazosin Related Compound B | Not available | C19H24N4O5 |
| Terazosin Related Compound C | Not available | C24H30Cl2N8O4 |
| Terbinafine Dimer Impurity Dihydrochloride Salt | Not available | C36H42Cl2N2 |
| Terbinafine EP Impurity A | 14489-75-9 | C12H13N |
| Terbinafine EP Impurity A HCl (Butenafine Impurity 11) | 65473-13-4 | C12H14ClN |
| Terbinafine EP Impurity B | 78628-81-6 | C21H25N |
| Terbinafine EP Impurity B HCl | 176168-78-8 | C21H26ClN |
| Terbinafine EP Impurity C | 187540-01-8 | C21H25N |
| Terbinafine EP Impurity C HCl | 877265-30-0 | C21H26ClN |
| Terbinafine EP Impurity D | 151222-50-3 | C22H27N |
| Terbinafine EP Impurity D HCl | 877265-33-3 | C22H28ClN |
| Terbinafine EP Impurity E | 934365-23-8 | C36H40N2 |
| Terbinafine EP Impurity F | 926281-74-5 | C21H25N |
| Terbinafine for system suitability | 78628-80-5 | C21H26ClN |
| Terbinafine Hydrochloride Imp. A (EP) as Hydrochloride: N-Methyl-C- (naphthalen-1-yl)methanamine Hydrochloride (Secondary Amine Hydrochloride) | 65473-13-4 | C12H14ClN |
| Terbinafine Hydrochloride Imp. B (EP) as Hydrochloride: (2Z)-N,6,6- Trimethyl-N-(naphthalen-1-ylmethyl)hept-2- en-4-yn-1-amine Hydrochloride (cis-Terbinafine Hydrochloride) | 176168-78-8 | C21H26ClN |
| Terbinafine Hydrochloride Imp. C (EP) as Hydrochloride: (2E)-N,6,6- Trimethyl-N-(naphthalen-2-ylmethyl)hept-2- en-4-yn-1-amine Hydrochloride (trans-iso-Terbinafine Hydrochloride) | 877265-30-0 | C21H26ClN |
| Terbinafine Hydrochloride Imp. D (EP) as Hydrochloride: (2E)-N,6,6- Trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]- hept-2-en-4-yn-1-amine Hydrochloride (4-Methylterbinafine Hydrochloride) | 877265-33-3 | C22H28ClN |
| Terbinafine impurity 7 (hydrochloride salt) | 152830-98-3 | C20H24ClN |
| Terbinafine impurity 8 | 98978-50-8 | C13H15N |
| Terbinafine impurity 10 | 296760-88-8 | C12H12N2O |
| Terbinafine N-Oxide Hydrochloride | Not available | C21H26ClNO |
| Terbinafine Related Compound A | 65473-13-4 | C12H14ClN |
| Terbinafine Related Compound B | 176168-78-8 | C21H26ClN |
| Terbinafine Related Compound C | 877265-30-0 | C21H26ClN |
| Terbinafine Related Compound D | 877265-33-3 | C22H28ClN |
| Terbutaline EP Impurity A | 99-10-5 | C7H6O4 |
| Terbutaline EP Impurity B | 94120-05-5 | C13H19NO3 |
| Terbutaline EP Impurity B Hemisulphate | 153657-83-1 | C13H21NO7S |
| Terbutaline EP Impurity C | 139508-58-0 | C12H17NO3 |
| Terbutaline EP Impurity D | 94109-61-2 | C19H23NO3 |
| Terbutaline EP Impurity D HBr | 1797117-23-7 | C19H24BrNO3 |
| Terbutaline Impurity 2 | 704909-67-1 | C15H16ClN |
| Terbutaline Impurity 3 | 635708-74-6 | C9H13Cl |
| Terbutaline Impurity 4 | 173200-56-1 | C9H14O |
| Terbutaline Impurity 5 | 138139-82-9 | C9H12O |
| Terbutaline Impurity 6 | 126764-17-8 | C9H13Cl |
| Terbutaline Impurity 15 | 62932-92-7 | C8H7BrO3 |
| Terbutaline impurity C | 139508-58-0 | C12H17NO3 |
| Terbutaline Impurity C | 139508-58-0 | C12H17NO3 |
| Terconazole Di-N-oxide Dihydrochloride | Not available | C26H33Cl4N5O5 |
| Terconazole N-Oxide | Not available | C26H31Cl2N5O4 |
| Terfenadine Imp. A (EP): 1-[4-(1,1-Dimethylethyl)phenyl]- 4-[4-(hydroxydiphenylmethyl)piperidin-1- yl]butan-1-one (Terfenadone) | 43076-30-8 | C32H39NO2 |
| Terfenadine Imp. G (EP): [1-[4-[4-(1,1-Dimethylethyl)- phenyl]but-3-enyl]piperidin-4- yl]diphenylmethanol | 104953-06-2 | C32H39NO |
| Terfenadine Imp. H (EP): [1-[4-[4-(1,1-Dimethylethyl)- phenyl]butyl]piperidin-4-yl]diphenylmethanol | 147158-67-6 | C32H41NO |
| Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) | 115-46-8 | C18H21NO |
| Terfenadine Imp. J (EP): Ethyl 1-[(4RS)-4-[4-(1,1- Dimethylethyl)phenyl]-4-hydroxybutyl]- piperidine-4-carboxylate | 100499-85-2 | C22H35NO3 |
| Terfenadine impurity A | 43076-30-8 | C32H39NO2 |
| Teriflunomide | 163451-81-8 | C12H9F3N2O2 |
| Terlipressin for NMR identification | 14636-12-5 | C52H74N16O15S2 |
| Terpin impurity D | 565-50-4 | C10H20O2 |
| Terpineol-4-o- β- D-glucoside | 69251-96-3 | C26H32O11 |
| tert-Butyl 2-(hydroxymethyl)-5,6-dihydroimidazo[1,2-a]pyrazine-7 (8H)-carboxylate | 1250996-70-3 | C12H19N3O3 |
| tert-butyl 4-(2-oxo-1,2-dihydro-3H-imidazo[4,5-b]pyridin-3-yl)piperidine-1-carboxylate | 1146515-11-8 | C16H22N4O3 |
| tert-butyl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate | 781649-87-4 | C16H22N4O3 |
| tert-butyl 4-((2-aminopyridin-3-yl)amino)piperidine-1-carboxylate | 781649-86-3 | C15H24N4O2 |
| tert-butyl 4-((3-aminopyridin-2-yl)amino)piperidine-1-carboxylate | 1071154-76-1 | C15H24N4O2 |
| tert-Butyl 4-(Phenylamino)piperidine-1-carboxylate | 125541-22-2 | C16H24N2O2 |
| tert-butyl 4-fluoro-3-oxopiperidine-1-carboxylate | 1334413-33-0 | C10H16FNO3 |
| tert-butyl 5-(hydroxymethyl)-2-azabicyclo[2.2.2]octane-2-carboxylate | 2169645-47-8 | C13H23NO3 |
| tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate | 361440-67-7 | C11H18N2O3 |
| tert-butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate | 1231755-15-9 | C9H15F3N2O3 |
| tert-butyl (3S,4R)-4-fluoro-3-hydroxypiperidine-1-carboxylate | 1174020-46-2 | C10H18FNO3 |
| tert-Butyl [(1S)-2-((1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl)-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate | 709031-43-6 | C23H33N3O4 |
| tert-Butyl N-((1S)-1-Benzyl-3-chloro-2-oxopropyl)carbamate | 102123-74-0 | C15H20ClNO3 |
| tert-Butyl N-[2-(2,6-Dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]carbamate | 1537890-74-6 | C18H21N3O5 |
| tert-Butyl N-[(1S)-1-((2S)-Oxiran-2-yl)-2-phenylethyl]carbamate | 98737-29-2 | C15H21NO3 |
| tert-Butyl N-[(1S,2R)-1-Benzyl-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]propyl]carbamate | 191226-98-9 | C25H35N3O7S |
| tert-Butyl N-[(1S,2S)-1-Benzyl-3-[(tert-butoxycarbonylamino)-[[4-(2-pyridyl)phenyl]methyl]amino]-2-hydroxy-propyl]carbamate | 198904-86-8 | C32H42N4O5 |
| tert-Octylamine | 107-45-9 | C8H19N |
| Tertiazole phosphate control | 856867-55-5 | C17H16FN6O6P |
| Testosterone 2-Nonyl-3-oxo-tridecanoate | Not available | C41H68O4 |
| Testosterone Acetate | 1045-69-8 | C21H30O3 |
| Testosterone decanoate for system suitability | 5721-91-5 | C29H46O3 |
| Testosterone enantate for peak identification | 315-37-7 | C26H40O3 |
| Testosterone enantate for system suitability | 315-37-7 | C26H40O3 |
| Testosterone Enantate Imp. B (EP): 3-Oxoandrost-4-en-17 -yl Hexanoate (Testosterone Caproate) | 10312-45-5 | C25H38O3 |
| Testosterone Enantate Imp. D (EP): 17 -Hydroxyandrost-4-en- 3-one (Testosterone) | 58-22-0 | C19H28O2 |
| Testosterone enantate impurity H | 162890-98-4 | C33H54O4 |
| Testosterone for ID and assay | 58-22-0 | C19H28O2 |
| Testosterone Imp. A (EP): Androst-4-ene-3,17-dione (Androstenedione) | Not available | C19H26O2 |
| Testosterone Imp. B (EP): 3-Ethoxyandrosta-3,5-dien- 17-one (Androstenedione Ethylenolether) | 972-46-3 | C21H30O2 |
| Testosterone Imp. C (EP): 17 -Hydroxyandrost-4-en- 3-one (Epitestosterone) | 481-30-1 | C19H28O2 |
| Testosterone Imp. D (EP): Androst-4-ene-3 ,17 -diol ( 4-Androstenediol) | 1156-92-9 | C19H30O2 |
| Testosterone Imp. E (EP): 3-Oxoandrost-4-en-17 -yl Acetate (Testosterone Acetate) | 1045-69-8 | C21H30O3 |
| Testosterone Imp. F (EP): 17 -Hydroxy-5 -androstan- 3-one (Androstanolone, Stanolone) | 521-18-6 | C19H30O2 |
| Testosterone Imp. G (EP): Androsta-1,4-diene-3,17-dione (Androstadienedione) | 897-06-3 | C19H24O2 |
| Testosterone Imp. H (EP): 17 -Hydroxyandrosta-1,4-dien- 3-one (Boldenone) | 846-48-0 | C19H26O2 |
| Testosterone Imp. I (EP): 17 -Hydroxyandrosta-4,6- dien-3-one ( 6-Testosterone) | 2484-30-2 | C19H26O2 |
| Testosterone Imp. J (EP): 3-Methoxyandrosta-3,5-dien- 17-one (Androstenedione Methylenolether) | 57144-06-6 | C20H28O2 |
| Testosterone impurity I | 2484-30-2 | C19H26O2 |
| Testosterone impurity I CRS | 2484-30-2 | C19H26O2 |
| Testosterone isocaproate for system suitability | 15262-86-9 | C25H38O3 |
| Testosterone Isocaproate Imp. A (EP): Testosterone | 58-22-0 | C19H28O2 |
| Testosterone Isocaproate Imp. B (EP): 3-Oxoandrost-4-en-17 -yl Acetate (Testosterone Acetate) | 1045-69-8 | C21H30O3 |
| Testosterone Isocaproate Imp. C (EP): Testosterone Propionate | 57-85-2 | C22H32O3 |
| Testosterone Isocaproate Imp. D (EP): 3-Oxoandrost-4-en-17 -yl 2-Methylpropanoate (Testosterone Isobutyrate) | 1169-49-9 | C23H34O3 |
| Testosterone Isocaproate Imp. E (EP): 3-Oxoandrost-4-en-17 -yl Hexanoate (Testosterone Caproate) | 10312-45-5 | C25H38O3 |
| Testosterone Isocaproate Imp. F (EP): Testosterone Enantate | 315-37-7 | C26H40O3 |
| Testosterone Laurate | 59232-78-9 | C31H50O3 |
| Testosterone propionate for system suitability | 57-85-2 | C22H32O3 |
| Testosterone Propionate Imp. A (EP): 3-Oxoandrost-4-en-17 -yl Acetate (Testosterone Acetate) | 1045-69-8 | C21H30O3 |
| Testosterone Propionate Imp. B (EP): 3-Oxoandrost-4-en-17 -yl 2-Methyl- propanoate (Testosterone Isobutyrate) | 1169-49-9 | C23H34O3 |
| Testosterone Propionate Imp. C (EP): Testosterone | 58-22-0 | C19H28O2 |
| Testosterone Propionate Imp. D (EP): 3-Oxoandrosta-1,4-dien-17 -yl Propanoate | 977-32-2 | C22H30O3 |
| Testosterone Propionate Imp. E (EP): 3-Oxoandrosta-4,6-dien-17 -yl Propanoate | 25862-97-9 | C22H30O3 |
| Testosterone Related Compound C | 481-30-1 | C19H28O2 |
| Testosterone Related Compound I | 2484-30-2 | C19H26O2 |
| Testosterone Ricinoleic Acid Ester | Not available | C37H60O4 |
| Tetrabromobisphenol Impurity 1 | 37853-61-5 | C17H16Br4O2 |
| Tetrabromobisphenol Impurity 2 | 3072-84-2 | C21H20Br4O4 |
| Tetrabromobisphenol Impurity 3 | 42757-55-1 | C18H14Br8O4S |
| Tetrabromobisphenol Impurity 4 | 70156-79-5 | C14H10Br4O4S |
| Tetrabromobisphenol Impurity 5 | 42757-54-0 | C18H14Br4O4S |
| Tetracaine Chloride | 15302-10-0 | C15H20Cl2N2O |
| Tetracaine EP Impurity C | 71839-12-8 | C12H17NO2 |
| Tetracaine for system suitability | 136-47-0 | C15H25ClN2O2 |
| Tetracaine Hydrochloride Imp. A (EP): 4-Aminobenzoic Acid | 150-13-0 | C7H7NO2 |
| Tetracaine Hydrochloride Imp. B (EP): 4-(Butylamino)benzoic Acid | 4740-24-3 | C11H15NO2 |
| Tetracaine Hydrochloride Imp. C (EP): Methyl 4-(Butylamino)benzoate | 71839-12-8 | C12H17NO2 |
| Tetracaine Hydroxyl Impurity | 490-98-2 | C15H24N2O3 |
| Tetracaine Impurity 1 (Benzocaine EP Impurity H) | 619-45-4 | C8H9NO2 |
| Tetracaine Impurity 2 (Benzocaine) | 94-09-7 | C9H11NO2 |
| Tetracaine Impurity 3 | 94-14-4 | C11H15NO2 |
| Tetracaine Impurity 4 | 94-32-6 | C13H19NO2 |
| Tetracaine Impurity 5 | 92726-05-1 | C15H23NO2 |
| Tetracaine Impurity 6 | 10012-47-2 | C11H16N2O2 |
| Tetracaine Impurity 6 HCl | 17599-02-9 | C11H17ClN2O2 |
| Tetracaine Impurity 8 | 65213-46-9 | C17H27NO2 |
| Tetracaine Impurity 10 | 4740-24-3 | C11H15NO2 |
| Tetracaine Impurity 11 | 1029292-13-4 | C15H23NO2 |
| Tetracaine Impurity 11 | 131719-63-6 | C11H17NO |
| Tetracaine Impurity 12 | 512175-79-0 | C13H19NO2 |
| Tetracaine Impurity 14 | 1056627-94-1 | C13H19NO2 |
| Tetracaine Impurity 16 | 398469-99-3 | C16H25NO2 |
| Tetracaine Impurity 18 | 794457-79-7 | C11H16N2O2 |
| Tetracaine Impurity 20 | 1152620-27-3 | C13H20N2O |
| Tetracaine Impurity 26 | 38152-22-6 | C11H14N2O4 |
| Tetracaine N-Oxide | 55750-02-2 | C15H24N2O3 |
| Tetracaine Related Compound B | 4740-24-3 | C11H15NO2 |
| Tetracaine Related Compound C | 71839-12-8 | C12H17NO2 |
| Tetracaine Sulfate | 149-15-5 | C36H62N4O8S |
| Tetracycline Hydrochloride Imp. A (EP) as Hydrochloride: (4R,4aS,5aS,6S,12aS)-4- (Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11- dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride (4-Epitetracycline Hydrochloride) | 23313-80-6 | C22H25ClN2O8 |
| Tetracycline impurity 2 | 79-85-6 | C22H24N2O8 |
| Tetracycline impurity 4 | 127-33-3 | C21H21ClN2O8 |
| Tetracycline impurity 6 | 514-53-4 | C22H23ClN2O8 |
| Tetracycline impurity 7 | 7518-17-4 | C22H22N2O7 |
| Tetracycline impurity 8 | 1665-56-1 | C22H22N2O7 |
| Tetracycline impurity 9 | 81163-11-3 | C22H21ClN2O7 |
| Tetracycline impurity 10 | 158018-53-2 | C22H22Cl2N2O7 |
| Tetracycline impurity 11 | 4497-08-9 | C22H21ClN2O7 |
| Tetracycline impurity 12 | 2013-58-3 | C22H21ClN2O8 |
| Tetracycline impurity 14 | 53864-51-0 | C20H20N2O8 |
| Tetracycline impurity 16 | 319426-63-6 | C28H34N2O13 |
| Tetradecylphosphocholine | 77733-28-9 | C19H42NO4P |
| Tetrahydro Furosemide | 4793-38-8 | C12H15ClN2O5S |
| tetrahydro-1H-1-benzazepin-3-yl]amino]-4-phenylbutanoic Acid (Benazeprilat) | 86541-78-8 | C22H24N2O5 |
| Tetrahydro-2-oxo-3-furanonitrile | 27512-26-1 | C5H5NO2 |
| Tetrahydrocortisol | 53-02-1 | C21H34O5 |
| Tetrahydrozoline Related Compound B | 945389-41-3 | C13H14N2 |
| Tetrahydrozoline Related Compound C | 1914-65-4 | C11H12O2 |
| Tetrahydrozoline Related Compound E | 84460-89-9 | C13H18N2O |
| Tetraisopropyl methylenediphosphonate | 1660-95-3 | C13H30O6P2 |
| Tetrakis(1-methylethyl) Methylenediphosphonate | 1660-95-3 | C13H30O6P2 |
| Tetraxetan Related Compound A | 2101625-18-5 | C18H32N4O8 |
| Tetrazepam Imp. B (EP): 7-Chloro-5-cyclohexyl-1,3- dihydro-2H-1,4-benzodiazepin-2-one | 1789-33-9 | C15H17ClN2O |
| Tetrazepam Imp. C (EP): 7-Chloro-5-cyclohexyl-1-methyl- 1,3-dihydro-2H-1,4-benzodiazepin-2-one | 1784-78-7 | C16H19ClN2O |
| Tetrazepam Imp. E (EP): 7-Chloro-5-(cyclohex-1-enyl)-1,3- dihydro-2H-1,4-benzodiazepin-2-one (Nortetrazepam) | 10379-11-0 | C15H15ClN2O |
| Tetrazepam impurity C | 1784-78-7 | C16H19ClN2O |
| Tetrazoline hydrochloride EP impurity A | 56536-96-0 | C11H11N |
| Tetrazolium impurity 1 | 1448724-09-1 | C25H27N9 |
| Tetryzoline Hydrochloride Imp. A (EP): (1RS)-1,2,3,4-Tetrahydronaphthalene- 1-carbonitrile ( -Cyanotetraline) | 56536-96-0 | C11H11N |
| Thalidomide Impurity 1 | 26581-81-7 | C13H12N2O3 |
| The compound was PHA 568487 | 527680-56-4 | C16H20N2O3 |
| Thebaine | 115-37-7 | C19H21NO3 |
| Thebaine N-Oxide | 81600-02-4 | C19H21NO4 |
| Thebaol Acetate | 47192-97-2 | C18H16O4 |
| Theophyllidine Hydrochloride | 116131-08-9 | C6H11ClN4O |
| Theophylline EP Impurity B | 1076-22-8 | C6H6N4O2 |
